As the country grapples with rising cases of coronavirus and mosquito-borne dengue, there has been a resurgence of another mosquito-borne disease, Chikungunya, in Dhaka.

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

Dr. Harindu Wijesinghe is a medical specialist in Rheumatology and Rehabilitation, as well as in Sports Medicine. He ...

Local door-to-door surveys will be conducted to check for symptoms in other residents of the commune, and thorough scans of ...

Bavarian Nordic has commenced a Phase III trial of its chikungunya vaccine, CHIKV VLP, targeting the paediatric population ...

UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...

Hundreds of cases have been imported in recent months after an outbreak in Réunion. The disease is spread by tiger mosquitoes ...

A landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...

Results from the Phase II VLA1553-221 trial show that a full dose of Ixchiq demonstrated a 96.5% seroresponse rate in ...

Paris: Health authorities in France have confirmed the first locally transmitted case of mosquito-borne chikungunya this year ...